First Time Loading...
H

Hang Lung Group Ltd
HKEX:10

Watchlist Manager
Hang Lung Group Ltd
HKEX:10
Watchlist
Price: 8.68 HKD -8.82% Market Closed
Updated: May 8, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

231.5B
+3%
Assets
Growth Rates:
1 Year
+2%
3 Years
+3%
5 Years
+17%
7 Years
+24%
10 Years
+16%
137.1B
+3%
Liabilities
Growth Rates:
1 Year
+3%
3 Years
+3%
5 Years
+22%
7 Years
+24%
10 Years
+7%
94.4B
+3%
Equity
Growth Rates:
1 Year
+2%
3 Years
+2%
5 Years
+9%
7 Years
+25%
10 Years
+34%

Balance Sheet Decomposition
Hang Lung Group Ltd

231.5B
Assets
137.1B
Liabilities
231.5B
Assets
137.1B
Liabilities
Current Assets 24B
Cash & Short-Term Investments 6.3B
Receivables 3.4B
Other Current Assets 14.2B
Non-Current Assets 207.4B
Long-Term Investments 205.5B
PP&E 328m
Other Non-Current Assets 1.6B
Current Liabilities 15.1B
Accounts Payable 10.1B
Other Current Liabilities 4.9B
Non-Current Liabilities 122B
Long-Term Debt 46.5B
Other Non-Current Liabilities 75.5B

Balance Sheet
Hang Lung Group Ltd

Rotate your device to view
Balance Sheet
Currency: HKD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2 618
1 571
1 648
1 452
1 032
831
1 591
4 432
2 314
6 343
Cash
2 618
1 571
1 648
1 452
1 032
831
1 591
4 432
2 314
6 343
Short-Term Investments
37 705
29 911
22 876
17 066
9 624
2 829
5 202
4 708
3 471
3 482
Total Receivables
1 947
1 170
3 958
2 078
2 061
2 298
3 531
3 555
3 589
3 441
Accounts Receivables
1 947
1 170
3 958
2 078
2 061
2 298
3 531
3 555
3 589
3 441
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
4 068
3 852
2 374
1 634
2 463
5 662
8 009
10 811
11 689
14 244
Other Current Assets
0
0
0
540
101
0
69
0
0
0
Total Current Assets
46 338
36 504
30 856
22 770
15 281
11 620
18 402
23 506
21 063
24 028
PP&E Net
306
338
1 446
218
213
231
250
286
317
328
PP&E Gross
306
338
1 446
218
213
231
250
286
317
328
Accumulated Depreciation
398
446
489
530
560
574
630
706
739
644
Intangible Assets
0
0
0
1 182
1 182
1 182
1 182
1 182
1 182
1 182
Long-Term Investments
157 268
157 502
152 704
171 616
181 918
200 202
204 814
212 963
203 828
205 769
Other Long-Term Assets
1 461
1 362
1 363
2
3
4
91
84
144
145
Total Assets
205 373
N/A
195 706
-5%
186 369
-5%
195 788
+5%
198 597
+1%
213 239
+7%
224 739
+5%
238 021
+6%
226 534
-5%
231 452
+2%
Liabilities
Accounts Payable
8 249
7 353
6 761
4 669
3 786
6 001
7 968
7 517
6 314
6 713
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
7 937
6 640
568
3 036
3 382
3 264
7 889
8 110
4 756
4 464
Other Current Liabilities
1 606
577
982
3 013
3 209
3 598
3 544
3 824
3 855
3 902
Total Current Liabilities
17 792
14 570
8 311
10 718
10 377
12 863
19 401
19 451
14 925
15 079
Long-Term Debt
32 158
30 690
30 551
25 341
27 589
28 165
31 209
38 109
41 490
46 507
Deferred Income Tax
10 727
10 144
9 494
10 173
9 895
13 884
14 790
15 974
14 906
14 950
Minority Interest
68 670
64 832
62 355
66 419
64 289
67 033
67 234
68 645
62 394
60 556
Total Liabilities
129 347
N/A
120 236
-7%
110 711
-8%
112 651
+2%
112 150
0%
121 945
+9%
132 634
+9%
142 179
+7%
133 715
-6%
137 092
+3%
Equity
Common Stock
3 893
3 893
4 065
4 065
4 065
4 065
4 065
4 065
4 065
4 065
Retained Earnings
67 354
70 048
73 234
77 762
83 181
89 140
86 320
88 169
90 906
93 493
Additional Paid In Capital
0
0
0
0
0
0
0
0
0
0
Unrealized Security Profit/Loss
38
0
0
68
69
68
63
61
61
61
Other Equity
4 741
1 529
1 641
1 242
868
1 979
1 657
3 547
2 213
3 259
Total Equity
76 026
N/A
75 470
-1%
75 658
+0%
83 137
+10%
86 447
+4%
91 294
+6%
92 105
+1%
95 842
+4%
92 819
-3%
94 360
+2%
Total Liabilities & Equity
205 373
N/A
195 706
-5%
186 369
-5%
195 788
+5%
198 597
+1%
213 239
+7%
224 739
+5%
238 021
+6%
226 534
-5%
231 452
+2%
Shares Outstanding
Common Shares Outstanding
1 355
1 355
1 362
1 362
1 362
1 362
1 362
1 362
1 362
1 362

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.